Completed NA INTERVENTIONAL 2-arm NCT01080482

Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fasting Condition

A Randomized, Single Dose, Open Label, Bioequivalence Study of Tacrolimus Capsules 5 mg in Normal Healthy Male Subjects Under Fasting Condition

Sponsor: Panacea Biotec Ltd

Conditions Healthy Volunteers

Interventions Tacrolimus 5 mg Capsule

Updated 6 times since 2017 Last updated: Mar 3, 2010 Started: Sep 30, 2007 Primary completion: Oct 31, 2007 Completion: Oct 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01080482, this NA trial focuses on Healthy Volunteers and remains completed. Sponsored by Panacea Biotec Ltd, it has been updated 6 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Sep 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Panacea Biotec Ltd

Data source: Panacea Biotec Ltd

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Navi Mumbai, India